Free shipping on all orders over $ 500

Linaclotide

Cat. No. M7526

All AbMole products are for research use only, cannot be used for human consumption.

Linaclotide Structure
Size Price Availability Quantity
1mg USD 60 In stock
2mg USD 90 In stock
5mg USD 140 In stock
10mg USD 235 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

In vitro: Linaclotide inhibits in vitro [125I]-STa binding to intestinal mucosal membranes from wt mice in a concentration-dependent manner. In contrast, [125I]-STa binding to these membranes from GC-C null mice is significantly decreased. After incubation in vitro in jejunal fluid for 30 min, linaclotide is completely degraded. Linaclotide acts on guanylate cyclase-C receptors on the luminal membrane to increase chloride and bicarbonate secretions into the intestine and inhibit the absorption of sodium ions, thus increasing the secretion of water into the lumen and improving defecation; the drug is minimally absorbed into the systemic circulation.

In vivo: Pharmacokinetic analysis shows very low oral bioavailability (0.10%). In intestinal secretion and transit models, linaclotide exhibits significant pharmacological effects in wt, but not in GC-C null mice: induction of increased fluid secretion into surgically ligated jejunal loops is accompanied by the secretion of elevated levels of cyclic guanosine-3',5-monophosphate and accelerated gastrointestinal transit. Linaclotide significantly increases weekly spontaneous bowel movements and complete spontaneous bowel movements (CSBMs) while reducing abdominal pain in patients with chronic constipation.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models female CD-1 mice
Formulation
Dosages 8 mg/kg
Administration i.v.
Chemical Information
Molecular Weight 1526.74
Formula C59H79N15O21S6
CAS Number 851199-59-2
Solubility (25°C) DMSO 30 mg/mL
Water 9 mg/mL (adjust pH to 2 with HCl)
Storage -20°C, dry, sealed
References

[1] Kang SB, et Pharmacol Res Perspect. A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa.

Related Guanylate Cyclase Products
Riociguat (BAY 63-2521)

Riociguat (BAY 63-2521) is an oral soluble guanylate cyclase (GC) stimulator, used in the research of ipulmonary hypertension.

A 350619 hydrochloride

A 350619 hydrochloride is a soluble guanylyl cyclase (sGC) activator.

BAY 41-2272

BAY 41-2272 is a soluble guanylyl cyclase (sGC) activator.

BAY 41-8543

BAY 41-8543 is a guanylyl cyclase (sGC) stimulator.

Ebselen Oxide

Ebselen oxide is a potent inhibitor of a-Methylacyl coenzyme A racemase (AMACR).

  Catalog
Abmole Inhibitor Catalog




Keywords: Linaclotide supplier, Guanylate Cyclase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.